CervoMed
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $8 | $322 | $1,757 |
Gross Profit | 322 | -3,350 | ||
EBITDA | -8,110 | -8,331 | -7,726 | -6,616 |
EBIT | -7,726 | -6,616 | ||
Net Income | -7,964 | -8,087 | -7,726 | -6,258 |
Net Change In Cash | 0 | 8 | 322 | 1,757 |
Free Cash Flow | -8,018 | -6,575 | -6,465 | -6,514 |
Cash | 7,941 | 8,235 | 9,437 | 8,320 |
Basic Shares | 9,258 | 9,252 | 9,252 | 8,950 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,006 | $9,738 | $7,145 | $0 |
Gross Profit | -9,060 | -1,294 | -1,336 | |
EBITDA | -28,294 | -18,227 | -7,812 | -3,475 |
EBIT | -16,290 | -2,171 | -15,972 | |
Net Income | -26,966 | -16,290 | -2,171 | -15,591 |
Net Change In Cash | 4,006 | 9,738 | 7,145 | 0 |
Free Cash Flow | -23,449 | -16,530 | -7,449 | -2,572 |
Cash | 8,235 | 8,999 | 7,792 | 4,093 |
Basic Shares | 9,041 | 8,073 | 2,661 | 518 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.86 |
2025-12-31 | -$0.88 |
2025-09-30 | -$0.84 |
2025-06-30 | -$0.70 |